These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18596084)

  • 1. Safety of linezolid in patients with baseline thrombocytopenia.
    Grim SA; Rene L; Gupta S; Clark NM
    J Antimicrob Chemother; 2008 Oct; 62(4):850-1. PubMed ID: 18596084
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid-related immune-mediated severe thrombocytopenia.
    Pascoalinho D; Vilas MJ; Coelho L; Moreira P
    Int J Antimicrob Agents; 2011 Jan; 37(1):88-9. PubMed ID: 21075603
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
    Grau S; Morales-Molina JA; Mateu-de Antonio J; Marín-Casino M; Alvarez-Lerma F
    J Antimicrob Chemother; 2005 Aug; 56(2):440-1. PubMed ID: 15956097
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?
    Legout L; Valette M; Dezeque H; Nguyen S; Lemaire X; Loïez C; Caillaux M; Beltrand E; Dubreuil L; Yazdanpanah Y; Migaud H; Senneville E
    J Antimicrob Chemother; 2010 Oct; 65(10):2224-30. PubMed ID: 20675299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
    Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
    J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid for endocarditis: a case series of 14 patients.
    Tascini C; Bongiorni MG; Doria R; Polidori M; Iapoce R; Fondelli S; Tagliaferri E; Soldati E; Di Paolo A; Leonildi A; Menichetti F
    J Antimicrob Chemother; 2011 Mar; 66(3):679-82. PubMed ID: 21393234
    [No Abstract]   [Full Text] [Related]  

  • 9. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
    Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
    Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y
    J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia in patients treated with linezolid.
    Viswanathan P; Iarikov D; Wassel R; Davidson A; Nambiar S
    Clin Infect Dis; 2014 Oct; 59(8):e93-5. PubMed ID: 24965346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
    Spellberg B; Yoo T; Bayer AS
    J Antimicrob Chemother; 2004 Oct; 54(4):832-5. PubMed ID: 15317746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic acidosis and linezolid-induced pancytopaenia.
    Carbajo T; Fenollosa M; Pons R; Calvo C
    Nefrologia; 2011; 31(1):107-8. PubMed ID: 21270922
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
    Tangg SJ; Zhang Q; Zheng LH; Sun H; Gu J; Hao XH; Liu YD; Yao L; Xiao HP
    Jpn J Infect Dis; 2011; 64(6):509-12. PubMed ID: 22116331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic effects of linezolid versus vancomycin.
    Young LS
    Clin Infect Dis; 2004 Apr; 38(8):1065-6. PubMed ID: 15095208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of a new antibiotic in Norway].
    Brubakk O; Bjørneklett A; Sjursen H; Viggen B
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1931-2. PubMed ID: 17700733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.